Products Market Alerts MyCollection Price Database Become a Partner Gallery ...
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA. Shares in the company gained almost 24% ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果